ArticleJHEP reports : innovation in hepatology2021

A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation.

Frederik Nevens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.